| abstract |
(57) [Summary] The following formula I Wherein R 1 is alkyl, R 2 is alkyl, halogenalkyl, alkenyl, halogenalkenyl, alkynyl, halogenalkynyl, -A 1 -O-N = CH-Ph or -A 2 -W, where A 1 is C 2 -C 4 alkylene which may be substituted, phenyl which may be substituted by Ph, alkylene which A 2 may be substituted, alkenylene, alkyleneoxyalkylene, phenyl which may be substituted by W, Pyridyl, thienyl, R 3 is substituted alkyl, optionally substituted cycloalkyl, cycloalkenyl, optionally substituted 5-membered saturated heterocycle (in addition to carbon ring members, 1 or 2 oxygen and / or Or optionally substituted 6-membered or 7-membered saturated or mono- or di-unsaturated heterocyclic ring (carbon ring member) And optionally having 1 or 2 nitrogen atoms and 1 oxygen or sulfur atom), optionally substituted 5-membered heteroaromatic ring (in addition to carbon ring members, 1 or 2 nitrogen atoms) Having one oxygen or sulfur atom), optionally substituted phenyl, pyridyl, R 4 is hydrogen, alkyl, halogenalkyl, alkenyl, halogenalkenyl, alkynyl, halogenalkynyl, alkylcarbonyl, halogenalkylcarbonyl, substituted even if no good benzoyl, -S (= O) 2 -R c, -P (= O) (OR d) (OR e), - SiR f R g R h ( these R c, R d, R e , shea R f, R g, the R h mean independently of one another, each C 1 -C 10 alkyl, C 1 -C 10 halogenalkyl, means a phenyl optionally substituted), respectively Rohe xenon oxime ethers, process for their preparation, agents containing them, and their use. |